IKBKB and cancer: Further work is needed, both in animal models and patient tumoral samples, to unravel the context-dependencies of IKKβ functions in inflammation/cancer to better define the circumstances where the therapeutic benefits of systemic IKKβ inhibition may outweigh the risk of potential side-effects.